In this new era of targeted therapies, the role of clinical trials is more important than ever in providing patients with access to promising new therapies and advancing our knowledge through cutting-edge research.
Compass Oncology is an established research leader in communities across the Pacific Northwest region and offers clinical trials through Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.
At Compass Oncology, we sponsor more clinical trials than any other cancer treatment facility in the Portland-Vancouver area. Continuing to provide our community with access to promising new therapies that may become tomorrow's gold standard remains a top priority at Compass Oncology.
To learn more about our clinical trial options, please call our research nurses at the following locations:
• East Office: 503.231.2612
• Rose Quarter Cancer Center: 503.528.5002
• Vancouver Cancer Center: 360.449.6521 or 360.449.6522
• West Cancer Center: 971.708.7617 or 971.708.7618